Outcome of Board Meeting
Mangalam Drugs & Organics Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on September 28, 2015, inter alia, transacted the following business:Allotted 26,50,000 convertible share warrants at Rs. 65/- (including premium of Rs. 55/-) to Shri JB Pharma LLP, Promoter group on preferential basis in accordance with the Chapter VII of SEBI (ICDR) Regulation 2009. In terms of their issue the warrants are convertible...28-09-2015